These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 759072)

  • 1. Inhibition of hepatic drug metabolism by norethindrone.
    Field B; Lu C; Hepner GW
    Clin Pharmacol Ther; 1979 Feb; 25(2):196-8. PubMed ID: 759072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aging on hepatic elimination of cimetidine and subsequent interaction of aging and cimetidine on aminopyrine metabolism.
    Henderson GI; Speeg KV; Roberts RK; Perez A; Schenker S
    Biochem Pharmacol; 1988 Jul; 37(13):2667-73. PubMed ID: 3390226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatic microsomal drug metabolism by the immunosuppressive agent cyclosporin A.
    Moochhala SM; Renton KW
    Biochem Pharmacol; 1986 May; 35(9):1499-503. PubMed ID: 3707614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased hepatic drug demethylation in patients receiving chemo-immunotherapy.
    Lipton A; Hepner GW; White DS; Harvey HA
    Cancer; 1978 May; 41(5):1680-4. PubMed ID: 647621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test.
    Hepner GW; Uhlin SR; Lipton A; Harvey HA; Rohrer V
    JAMA; 1976 Oct; 236(14):1587-90. PubMed ID: 989131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
    Hepner GW; Vesell ES
    Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole: effects on oxidative drug metabolism.
    Henry DA; Somerville KW; Kitchingman G; Langman MJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):195-200. PubMed ID: 6487457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age and sex on the N-demethylation rate of 14C-aminopyrine, studied by the breath test.
    Pirotte J; El Allaf D
    Digestion; 1983; 28(4):210-5. PubMed ID: 6671482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
    Meredith CG; Maldonado AL; Speeg KV
    Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminopyrine metabolism in the presence of hyperbilirubinemia due to cholestasis or hepatocellular disease. Combined use of laboratory tests to study disease-induced alterations in drug disposition.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1977 May; 21(5):620-6. PubMed ID: 870274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited usefulness of the breath test in evaluation of drug metabolism: a study in human oral contraceptive users treated with dimethylaminoantipyrine and diazepam.
    Sonnenberg A; Koelz HR; Herz R; Benes I; Blum AL
    Hepatogastroenterology; 1980 Apr; 27(2):104-8. PubMed ID: 6783497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance.
    Schnegg M; Lauterburg BH
    J Hepatol; 1986; 3(2):164-71. PubMed ID: 3794298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of drug metabolism by cimetidine in man: dependence on pretreatment microsomal liver function.
    Röllinghoff W; Paumgartner G
    Eur J Clin Invest; 1982 Oct; 12(5):429-32. PubMed ID: 6816615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic metabolism of aminopyrine in patients with chronic renal failure.
    Scherrer S; Haldimann B; Küpfer A; Reubi F; Bircher J
    Clin Sci Mol Med; 1978 Feb; 54(2):133-40. PubMed ID: 620502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of in vivo plasma radioactivity clearance and 14CO2 breath elimination of model drugs in the rat: a study in regional hepatocyte function.
    Willson RA; Hart FE
    Toxicol Appl Pharmacol; 1981 Nov; 61(2):177-84. PubMed ID: 6798712
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical appraisal of 13C breath tests for microsomal liver function: aminopyrine revisited.
    Pijls KE; de Vries H; Nikkessen S; Bast A; Wodzig WK; Koek GH
    Liver Int; 2014 Apr; 34(4):487-94. PubMed ID: 24428683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The aminopyrine breath test.
    Perri F; Pastore M; Annese V; Andriulli A
    Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced drug elimination in congestive heart failure. Studies using aminopyrine as a model drug.
    Hepner GW; Vesell ES; Tantum KR
    Am J Med; 1978 Aug; 65(2):371-6. PubMed ID: 686023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.